New twist to an old problem: COVID-19 and idiopathic pulmonary fibrosis.
Adv Respir Med
; 89(1): 84-85, 2021.
Article
in English
| MEDLINE | ID: covidwho-1038736
ABSTRACT
Iidiopathic pulmonary fibrosis (IPF) diagnosis and treatment during this COVID-19 pandemic have been affected. COVID-19 has not only impacted the prognosis of these patients but also the approach to these patients. Pulmonary function tests (PFT) and lung biopsies are less encouraged now. Traditional antifibrotics used in IPF should be encouraged irrespective of patient lung function and in those with non-definite usual interstitial pneumonia in high resolution computed tomography.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Idiopathic Pulmonary Fibrosis
/
COVID-19
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Adv Respir Med
Year:
2021
Document Type:
Article
Affiliation country:
ARM.a2020.0177
Similar
MEDLINE
...
LILACS
LIS